Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial.
By C. Loprinzi, J. Kugler, J. Sloan, J. Mailliard, Beth I Lavasseur, D. Barton, P. Novotny, S. Dakhil, K. Rodger, T. Rummans and 1 more. The Lancet, 2000
746 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Oncology, Surgery
View Paper: https://www.semanticscholar.org/paper/f955509a0e3904b0e235c8113bfa210a03b81ed8
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
Citations in the corpus
- Major depression after breast cancer: a review of epidemiology and treatment. (2008, background): “, tamoxifen and aromatase inhibitors) and the contraindication of estrogen replacement therapy in this population [2,72].”